SciELO - Scientific Electronic Library Online

 
vol.46 issue4Validity of the Pulmonary Embolism Rule-Out Criteria (PERC) for ruling out pulmonary embolism in low-risk patients at high altitudesIt is time to adapt the definition of chronic kidney disease according to age author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Acta Medica Colombiana

Print version ISSN 0120-2448

Abstract

GANDARA-RICARDO, JAIRO ALFONSO et al. Current treatment for heart failure with reduced ejection fraction. A systematic review of the new therapies. Acta Med Colomb [online]. 2021, vol.46, n.4, pp.26-42.  Epub Apr 28, 2022. ISSN 0120-2448.  https://doi.org/10.36104/amc.2021.2108.

Introduction:

heart failure with reduced ejection fraction has a growing therapeutic arsenal. Thus, the indications for each therapy must be refined.

Methods:

a systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, to update the systematic search performed in the development of the "Clinical Practice Guidelines for Prevention, Diagnosis, Treatment and Rehabilitation" (CPG) of the Colombian Ministry of Health.

Results:

six new clinical trials were found which substantially modify the main recommendations of the CPG. Angiotensin receptor antagonists combined with neprilysin inhibitors (ARNI), sodium-glucose cotransporter 2 (SGLT2) inhibitors, betablockers and mineralocorticoid receptor antagonists (MRA) are now the main core of treatment for patients with heart failure with reduced ejection fraction. Other therapeutic options should be considered after beginning and titrating the doses of these four medications.

Discussion:

given the robustness of the evaluating studies, the proposed practical scheme, as the central core with four fundamental therapeutic strategies, will improve the treatment of patients with heart failure and allow the stepwise inclusion of other alternatives, plotted as orbits, to impact on other individual outcomes. (Acta Med Colomb 2021; 46. DOI:https://doi.org/10.36104/amc.2021.2108).

Keywords : heart failure; epidemiology; mortality.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )